Resonant Capital Advisors LLC Raises Stock Holdings in Cardinal Health, Inc. $CAH

Resonant Capital Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 5.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,227 shares of the company’s stock after buying an additional 497 shares during the quarter. Resonant Capital Advisors LLC’s holdings in Cardinal Health were worth $1,550,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CAH. Greykasell Wealth Strategies Inc. purchased a new stake in Cardinal Health in the 1st quarter worth $26,000. Jones Financial Companies Lllp grew its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC increased its stake in shares of Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares in the last quarter. GW&K Investment Management LLC raised its position in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares during the last quarter. Finally, Harbor Asset Planning Inc. purchased a new position in Cardinal Health in the 2nd quarter valued at about $49,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on CAH shares. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners lifted their target price on shares of Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Finally, Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Price Performance

NYSE:CAH opened at $161.83 on Friday. The company’s 50-day moving average is $152.75 and its two-hundred day moving average is $152.88. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The firm has a market capitalization of $38.45 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 1.37 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s dividend payout ratio is 31.63%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares in the company, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.